Evidence map›Paper›PMID 32509740›Full record

ArticleFrontiers in bioengineering and biotechnology2020

Hybrid Injectable Sol-Gel Systems Based on Thermo-Sensitive Polyurethane Hydrogels Carrying pH-Sensitive Mesoporous Silica Nanoparticles for the Controlled and Triggered Release of Therapeutic Agents.

Monica Boffito, Alessandro Torchio, Chiara Tonda-Turo, Rossella Laurano, Miguel Gisbert-Garzarán, Julia C Berkmann, Claudio Cassino, Miguel Manzano, Georg N Duda, María Vallet-Regí and 2 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in bioengineering and biotechnology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 34 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 3 countries.

Monica BoffitoDepartment of Mechanical and Aerospace Engineering, Politecnico di Torino, Turin, Italy.
Alessandro TorchioDepartment of Mechanical and Aerospace Engineering, Politecnico di Torino, Turin, Italy.
Chiara Tonda-TuroDepartment of Mechanical and Aerospace Engineering, Politecnico di Torino, Turin, Italy.
Rossella LauranoDepartment of Mechanical and Aerospace Engineering, Politecnico di Torino, Turin, Italy.
Miguel Gisbert-GarzaránDepartamento de Química en Ciencias Farmacéuticas, Instituto de Investigación Sanitaria del Hospital, Universidad Complutense de Madrid, Madrid, Spain.
Julia C BerkmannJulius Wolff Institut, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Claudio CassinoDepartment of Science and Technological Innovation, Università del Piemonte Orientale, Alessandria, Italy.
Miguel ManzanoDepartamento de Química en Ciencias Farmacéuticas, Instituto de Investigación Sanitaria del Hospital, Universidad Complutense de Madrid, Madrid, Spain.
Georg N DudaJulius Wolff Institut, Charité - Universitätsmedizin Berlin, Berlin, Germany.
María Vallet-RegíDepartamento de Química en Ciencias Farmacéuticas, Instituto de Investigación Sanitaria del Hospital, Universidad Complutense de Madrid, Madrid, Spain.
Katharina Schmidt-BleekJulius Wolff Institut, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Gianluca CiardelliDepartment of Mechanical and Aerospace Engineering, Politecnico di Torino, Turin, Italy.
Polytechnic University of Turin · ITBerlin Institute of Health at Charité - Universitätsmedizin Berlin · DEUniversidad Complutense de Madrid · ESUniversità degli Studi del Piemonte Orientale “Amedeo Avogadro” · ITUniversity of Turin · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Injectable therapeutic formulations locally releasing their cargo with tunable kinetics in response to external biochemical/physical cues are gaining interest in the scientific community, with the aim to overcome the cons of traditional administration routes. In this work, we proposed an alternative solution to this challenging goal by combining thermo-sensitive hydrogels based on custom-made amphiphilic poly(ether urethane)s (PEUs) and mesoporous silica nanoparticles coated with a self-immolative polymer sensitive to acid pH (MSN-CS-SIP). By exploiting PEU chemical versatility, Boc-protected amino groups were introduced as PEU building block (PEU-Boc), which were then subjected to a deprotection reaction to expose pendant primary amines along the polymer backbone (PEU-NH

Indexed as

pH-sensitive mesoporous silica nanoparticlespolyurethaneself-immolative polymerstimuli-responsivethermo-sensitive hydrogelstriggered drug release

Identifiers

PMID32509740
PMCPMC7248334
OpenAlexW3026174611

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.